在缺血性中风中LncRNA调节及其应用前景
Qianqian Chen1, Xiangyi Xu1, Shun Li2
1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Neural regeneration research
|March 27, 2025
概括
长非编码RNAs (lncRNAs) 在通过调节基因表达来理解和治疗缺血性中风方面表现有前途. 需要进一步的研究来克服临床应用的挑战.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 缺血性中风具有深刻的,持久的影响.
- 了解分子机制,包括基因表达,至关重要.
- 调节性长非编码RNAs (lncRNAs) 是脑梗塞的一个关键研究领域.
研究的目的:
- 综合审查调节性lncRNAs在缺血性中风中的作用.
- 探索 lncRNAs 在治疗脑梗塞中的潜在临床应用.
- 为了确定涉及中风病理和治疗的特定 lncRNA.
主要方法:
- 在缺血性中风中对lncRNAs的研究的文献综述.
- 对lncRNA与microRNAs (miRNAs) 相互作用的分析.
- 检查动物模型和生物标志物中使用的lncRNAs.
主要成果:
- LncRNAs充当miRNA海绵,调节目标基因表达.
- 特定的lncRNAs (例如,NKILA,Meg8,H19) 在动物模型中显示出治疗潜力.
- 作为诊断和预后生物标志物,LncRNAs (例如FOXO3,XIST,RMST) 被研究.
结论:
- 调节性 lncRNA 在缺血性中风过程中起着重要的作用,如反损伤,细胞死亡和血管生成.
- LncRNAs为遗传水平的中风治疗提供了潜力.
- 临床应用面临挑战,包括效率,准准确性和需要进一步验证的副作用.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
siRNA - Small Interfering RNAs
16.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


